Novo Nordisk ADR
Novo Nordisk ADR (NVO) Options Open Interest
NVO options open interest is 1,466,161 contracts. The 2-week average daily volume is 60,976 contracts across the chain.
Read more
Monitoring NVO open interest helps you see where real money is positioned on Novo Nordisk ADR's options and which strikes are attracting the most commitment from traders. Novo Nordisk ADR's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor NVO options open interest in real time and find the strikes that matter.
Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising NVO options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Novo Nordisk ADR to settle.
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles.
In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where NVO open interest is concentrated. Our scanner maps Novo Nordisk ADR's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Novo Nordisk ADR's options open interest as the signal it is, not as an afterthought.
| 40.00 | 0.21 | 0.24 | 0.23 | 30% | +0.2424 | 2,073 |
| 39.50 | 0.33 | 0.39 | 0.36 | 30% | +0.3456 | 1,662 |
| 41.00 | 0.08 | 0.10 | 0.09 | 32% | +0.1114 | 1,249 |
| 45.00 | — | 0.03 | 0.03 | 56% | +0.0275 | 992 |
| 48.00 | — | 0.09 | 0.09 | 90% | +0.0477 | 879 |
| 38.00 | 0.24 | 0.27 | 0.26 | 28% | -0.2771 | 2,618 |
| 39.00 | 0.62 | 0.72 | 0.67 | 28% | -0.5393 | 1,515 |
| 40.00 | 1.34 | 1.50 | 1.42 | 32% | -0.7466 | 1,266 |
| 37.00 | 0.05 | 0.12 | 0.09 | 30% | -0.1109 | 1,057 |
| 37.50 | 0.13 | 0.16 | 0.15 | 28% | -0.1771 | 849 |
As of September 25, 2026
Follow the money
Track NVO open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.
Start your 14-day free trial→